National Comprehensive Cancer Network

Interactive CME


Educational Events & Programs

Click here to view the article.

On Friday, December 19, the Patient Advocacy Summit: Value Tools for Patients in Cancer Care at the National Press Club took place in Washington, D.C. The Patient Advocacy Summit provided an opportunity for a varied group of stakeholders including patients, patient advocacy organizations, providers, payers, industry, and government, to discuss current gaps of value tools, examine principles and parameters of future value tools for patients, and debate where the oncology community is headed on this important issue. If you have any questions, please contact Katy Winckworth-Prejsnar.

This activity is supported by an educational donation provided by Amgen. Sponsored by a contribution from Bristol-Myers Squibb. Supported by an unrestricted grant from Eisai. Supported by a grant from ImmunoGen. This activity is supported by a contribution from Lilly Oncology. Supported by an independent educational grant from Merck & Co., Inc. Supported by an unrestricted sponsorship from TESARO. This activity is supported by: AmerisourceBergen; ApoBiologix, a Division of ApoPharma, USA; Astellas; EMD Serono; Foundation Medicine, Inc.; Genentech; Gilead Sciences, Inc.; HELSINN; Incyte Corporation; ImpediMed; Infinity Pharmaceuticals; Janssen Oncology; Medivation, Inc.; Pharmacyclics LLC, An AbbVie Company; Taiho Oncology; Takeda Oncology; and Teva Oncology. This activity is sponsored by: AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; Celgene Corporation; Dendreon; and Novartis Oncology.


Access the Library of White Papers!

NCCN offers a broad library of white papers from previous summits that may be pertinent to your organization.

View Supporter Opportunities.

NCCN offers organizations various supporter opportunities.